Head and Neck Cancers

Latest News

Line illustration of a head, including the nasal cavity, mouth and throat on a gold background.
PYX-201 Receives FDA Fast Track Designation for Recurrent/Metastatic HNSCC

March 8th 2025

The FDA has granted PYX-201 fast track designation for treatment of recurrent or metastatic HNSCC after progression post-chemoimmunotherapy.

White line illustration of the head and neck, including the nasal cavity and throat, on a cornflower blue background
Petosemtamab/Pembrolizumab Receives FDA Breakthrough Designation for PD-L1+ HNSCC

February 28th 2025

Simple line illustration of a thyroid against a dark blue background
Thyroidectomy Without Radioiodine May Be Noninferior to Radioiodine Use in Thyroid Cancer

February 6th 2025

green background with FDA in blue text and approved with a checkmark in darker green text
FDA OKs Subcutaneous Nivolumab in Advanced/Metastatic Solid Tumors

December 27th 2024

Video Interviews
Podcasts

More News